Exelixis
EXEL
#1684
Rank
NZ$17.33 B
Marketcap
$60.69
Share price
1.62%
Change (1 day)
73.15%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company